French Luxury Stock News

Tikehau Capital (ENXTPA:TKO) is drawing attention as fund managers highlight its focus on energy transition and energy security assets, particularly manufacturers of critical equipment and local infrastructure solutions that attract capital-intensive clean energy funding. See our latest analysis for Tikehau Capital. The recent focus on energy transition and energy security sits against a mixed performance backdrop, with a 2.9% 7 day share price return, a 16.0% 30 day share price decline, and...

Nanobiotix reported first clinical data from the Johnson & Johnson sponsored Phase 2 CONVERGE trial of JNJ-1900 (NBTXR3) in stage 3 inoperable non small cell lung cancer. Results presented at a major conference showed initial signals of efficacy alongside an acceptable safety profile. The data mark the first readout from a pivotal trial of Nanobiotix’s lead asset in this lung cancer setting. For investors watching ENXTPA:NANO, this update lands after a period of strong share price...

Kekst CNC, a Publicis Groupe subsidiary, has appointed Lyndsey Estin as Co-CEO to lead U.S. operations. The move highlights Publicis Groupe’s focus on advanced communications capabilities in areas such as AI and cybersecurity. For investors tracking ENXTPA:PUB, this shift at Kekst CNC sits squarely in the core of Publicis Groupe’s communications and advisory activities. Kekst CNC is a global communications arm, and its work spans crisis counsel and complex corporate issues that many large...

In the current European market, investor sentiment is being shaped by geopolitical uncertainties and fluctuating energy prices, with indices like the STOXX Europe 600 showing modest gains amid these challenges. As economic conditions remain unpredictable, growth companies with high insider ownership can offer a unique appeal due to their potential for alignment between management and shareholder interests, which may be particularly valuable in navigating complex market environments.

ABIVAX Société Anonyme (ENXTPA:ABVX) is in focus after full year 2025 earnings showed revenue of €4.57 million and a net loss of €336.1 million, alongside fresh trial, leadership, financing, and index inclusion updates. See our latest analysis for ABIVAX Société Anonyme. The recent earnings release, positive Phase 3 safety update, leadership hires, ESOP related shelf registration, and FTSE All World Index inclusion come against a backdrop of a 1 year total shareholder return above 10x. At the...

If you are wondering whether Airbus is fairly priced or offering value at current levels, it helps to start with how its market performance lines up against underlying worth. The share price recently closed at €159.18, with returns of a 4.3% decline over 7 days, a 13.6% decline over 30 days, a 21.9% decline year to date, and around 0.0% over the last year, compared with 34.1% over 3 years and 69.6% over 5 years. Recent headlines around Airbus have focused on its role as a key aerospace and...

Eurazeo (ENXTPA:RF) has been removed from the FTSE All-World Index. The change affects the stock’s presence in a major global equity benchmark tracked by index funds and ETFs. This type of index action can influence trading activity and how institutional investors view the company. Eurazeo is a listed investment company with exposure to private equity style assets, which means its share often sits on the radar of global fund managers. Being dropped from a widely followed index such as the...

Investors were underwhelmed by the solid earnings posted by SergeFerrari Group SA ( EPA:SEFER ) recently. We have done...

The market for Capgemini SE's ( EPA:CAP ) shares didn't move much after it posted weak earnings recently. We think that...

One of the biggest stories of last week was how STIF Société anonyme ( EPA:ALSTI ) shares plunged 26% in the week since...

As the European markets navigate through uncertainties spurred by geopolitical tensions and energy price fluctuations, investor sentiment remains cautious yet discerning. In such a climate, growth companies with high insider ownership often stand out as potentially resilient investments due to the alignment of interests between insiders and shareholders, which can be particularly advantageous during periods of economic volatility.

Today is shaping up negative for 2CRSI S.A. ( EPA:AL2SI ) shareholders, with the analysts delivering a substantial...

Bolloré (ENXTPA:BOL) has drawn fresh attention after its board proposed an exceptional €1.5 per share dividend, about €4.2b, alongside 2025 results and a regular €0.08 per share dividend plan. See our latest analysis for Bolloré. The exceptional dividend proposal and 2025 earnings release have arrived after a mixed period, with a 3.96% three month share price return, a 1.17% year to date share price gain, but a 1 year total shareholder return decline of 11.46%, suggesting short term momentum...

Sanofi received FDA Breakthrough Therapy designation for oral venglustat targeting neurological symptoms in type 3 Gaucher disease. Sanofi reported positive phase 3 results for amlitelimab in atopic dermatitis. European regulators issued a positive opinion for Sarclisa subcutaneous with an on body injector for multiple myeloma, potentially introducing dual administration modes in the EU. Sanofi, traded as ENXTPA:SAN, is currently priced at €81.99 and has seen a 5.4% gain over the past week,...

If you are wondering whether ABIVAX Société Anonyme is priced attractively right now, the starting point is to compare what you pay today with what the business could be worth under different valuation lenses. The stock last closed at €89.20, after a 7 day return of an 18.5% decline and a 30 day return of a 13.1% decline, set against a very large 1 year gain and an 11.8x return over 3 years. Recent attention on ABIVAX Société Anonyme has been shaped by ongoing coverage of its position in the...

Ipsen (ENXTPA:IPN) has come into focus after presenting fresh preclinical data at the AACR congress for two first in class oncology candidates, IPN01203 and IPN60300, targeting difficult solid tumor indications. See our latest analysis for Ipsen. The latest oncology data and recent conference activity come at a time when Ipsen’s share price has reached €157.7, with recent momentum reflected in a 90 day share price return of 32.97% and a 1 year total shareholder return of 48.68%. This...

Thales has partnered with the Dominican Republic to launch the country's first electronic passport, integrating advanced cybersecurity for citizen data. The project establishes a secure e-passport system and ongoing cyber threat monitoring for the Dominican Republic's border and identity infrastructure. For investors tracking ENXTPA:HO, this agreement adds additional real world evidence of Thales' role in digital identity and security, alongside its existing defense and aerospace...

Investors in Innate Pharma S.A. ( EPA:IPH ) had a good week, as its shares rose 2.4% to close at €1.10 following the...

It's been a pretty great week for Netgem SA ( EPA:ALNTG ) shareholders, with its shares surging 11% to €0.76 in the...

Wondering whether EssilorLuxottica Société anonyme is starting to look attractively priced, or if the recent share price leaves little margin for error. The stock last closed at €194.80, with returns of 0.0% over 7 days, a 17.8% decline over 30 days, a 26.6% decline year to date, and a 25.8% decline over 1 year, set against gains of 23.8% over 3 years and 52.1% over 5 years. Recent moves in the share price sit against a backdrop of ongoing interest in the business and its role in the global...

How Accor’s Recent Share Performance Frames Today’s Setup Accor (ENXTPA:AC) has seen its share price fall about 17% over the past month and about 15% over the past 3 months, putting the hotel group’s current valuation and fundamentals back in focus for investors. See our latest analysis for Accor. That recent 17% 1 month share price decline sits against a 1 year total shareholder return of about a 3% decline and a 3 year total shareholder return of about 48%. This suggests shorter term...

Before getting into the numbers, it helps to know why Thales might be on your radar, especially if you are asking whether the current share price still represents value or if most of the opportunity is already reflected in the market. Recently, Thales shares closed at €237.90, with returns of 1.2% year to date, 85.1% over 3 years and 203.1% over 5 years. Over the last 7 days and 30 days the shares showed declines of 1.8% and 6.1% respectively, which can shift how investors think about both...

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...

Valeo (ENXTPA:FR) is investing $225 million in a new manufacturing facility in Texas. The plant will produce central compute units for General Motors' software-defined vehicles. The project supports one of the largest orders in Valeo's history and expands its US footprint. For investors watching the auto technology space, this move places Valeo more firmly among the suppliers building the electronics behind software-defined vehicles. The Texas facility connects directly to Valeo's existing...